☆ 4.4 Article

The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。
Editorial Material Endocrinology & Metabolism

Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes?

Roy W. Beck et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

添加到收藏夹
Article Endocrinology & Metabolism

Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration

Halis Kaan Akturk et al.

Summary: The study suggests that random CGM data loss up to 50% does not significantly affect the optimal sampling duration for CGM metrics, but losing data with longer gaps increases the MdAPE crossing threshold, requiring a longer optimal sampling duration.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

添加到收藏夹
Article Endocrinology & Metabolism

Robust Determination of the Optimal Continuous Glucose Monitoring Length of Intervention to Evaluate Long-Term Glycemic Control

Pau Herrero et al.

Summary: The study proposes a robust method to determine the minimum duration of CGM data required for reporting times in ranges and other glycemic metrics, suggesting that certain metrics can be robustly assessed within a 4-week period, while others evaluating hypoglycemia require longer window lengths.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

添加到收藏夹
Article Endocrinology & Metabolism

Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control

Tonya D. Riddlesworth et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

添加到收藏夹
研讨会 海报 问题 讨论圈 基金 期刊 论文 科研社交 资讯集成 审稿人 关于我们 常见问题 移动App 隐私条款 使用条款
© Peeref 2019-2024. All rights reserved.